David Happel

CIK 1623567 · President & CEO · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.22M

Companies

3

Total Filings

16

Lifetime Open-Market Net

-$591.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SGMT President & CEO 805,621 $6.48 $5.22M -$591.3K 10 2026-06-01
Horizon Therapeutics Public Ltd Co (HZNP) Delisted EVP, Commercial Dev & Strategy 9,239 $116.30 $1.07M $0 1 2017-10-26
Raptor Pharmaceutical Corp (RPTP) Delisted Chief Commercial Officer 0 $0 5 2016-10-26

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-10-26 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed +3,803 -$56.1K EDGAR
2016-10-26 Raptor Pharmaceutical Corp (RPTP) Delisted Mixed −37,873 -$340.9K EDGAR
2016-03-03 Raptor Pharmaceutical Corp (RPTP) Delisted Tax (F) −576 -$2.0K EDGAR
2016-02-11 Raptor Pharmaceutical Corp (RPTP) Delisted Grant (A) +25,017 $0 EDGAR
2015-02-11 Raptor Pharmaceutical Corp (RPTP) Delisted Grant (A) +5,229 $0 EDGAR
2014-11-28 Raptor Pharmaceutical Corp (RPTP) Delisted Grant (A) $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.